BREAKING: GenBioPro, the pharmaceutical company that makes a generic version of the abortion pill mifepristone, sued the FDA on Wednesday. The suit seeks to compel the FDA to allow GenBioPro to continue to sell the medication in the U.S.
“Once a drug has been through the rigorous FDA review process and received approval, federal law protects the right to market the drug,” said GenBioPro CEO Evan Massingill. “GenBioPro will use all regulatory and legal tools to protect access to mifepristone for patients and providers.”
the U.S. Food and Drug Administration on Wednesday, April 19, in Maryland federal court, where the agency is headquartered. The suit seeks an order to compel the FDA to allow GenBioPro to continue to sell the medication in the United States. GenBioPro estimates their generic medication comprises two-thirds of the mifepristone in the United States.in a Texas case that attempt to remove the medication from the market.
GenBioPro argued the company has the right to preserve the drug’s availability under the federal Food, Drug and Cosmetic Act , the FDA’s regulations and the company’s constitutional rights guaranteed by the Fifth Amendment of the United States Constitution.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on marketThe Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.
Read more »
As Supreme Court Weighs Next Steps on Abortion Pill, Protesters Rally and Pharma Company GenBioPro Sues FDA to Restore AccessAs the Supreme Court weighs its options on the abortion pill mifepristone, abortion and women’s rights supporters across the U.S. are protesting the latest efforts to restrict access to abortion.
Read more »
Abortion pill manufacturer sues FDA to keep drug on the marketThe Supreme Court is expected to rule today on whether to impose restrictions to abortion pills.
Read more »
Abortion pill maker sues FDA to preserve accessThe maker of the generic version of the abortion pill mifepristone sued the FDA today, hoping to bar the agency from rolling back access to the drug if the Supreme Court allows sweeping restrictions to take effect this week.
Read more »
Abortion Pill Manufacturer Sues FDA to Protect Mifepristone AccessGenBioPro, the manufacturer of a generic version of the abortion pill mifepristone, sued the Food and Drug Administration on Wednesday to prevent the drug from being taken off the market.
Read more »